NDatalyzeNDATF PB Ratio is 13.33 as of Jun. 29, 2026, which is 200% above its 10-year median of 4.44. Among 608 Healthcare Providers & Services companies, NDatalyze ranks worse than 91.61% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-29), NDatalyze's share price is $0.08. NDatalyze's Book Value per Share for the quarter that ended in Feb. 2026 was $0.01. Hence, NDatalyze's PB Ratio of today is 13.33.
The historical rank and industry rank for NDatalyze's PB Ratio or its related term are showing as below:
NDATF'
s PB Ratio Range Over the Past 10 Years
Min: 0.94 Med: 4.44 Max: 13.33
Current: 8.75
During the past 8 years, NDatalyze's highest PB Ratio was 13.33. The lowest was 0.94. And the median was 4.44.
NDATF's PB Ratio is ranked worse than 91.61% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 1.985
vs NDATF: 8.75
During the past 12 months, NDatalyze's average Book Value Per Share Growth Rate was -38.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -18.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -24.30% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of NDatalyze was 68.40% per year. The lowest was -32.90% per year. And the median was -15.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
NDatalyze PB Ratio Related Terms
NDatalyze PB Ratio Historical Data
* Premium members only.
The historical data trend for NDatalyze's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, NDatalyze's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NDatalyze PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NDatalyze's PB Ratio distribution charts can be found below:
* The bar in red indicates where NDatalyze's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
NDatalyze's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
NDatalyze (NDATF) has a PB Ratio of 13.33 as of Jun. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on NDatalyze and its competitors. This is 200% above median its historical median of 4.44. Over the past decade, NDatalyze's PB Ratio has ranged from 0.94 to 13.33. According to the industry distribution chart, NDatalyze ranks #557 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 91.6%.
Is NDatalyze's PB Ratio too high?
NDatalyze's current PB Ratio of 13.33 is 200% above median its 10-year median of 4.44. Over the past 10 years, this metric has ranged from a low of 0.94 to a high of 13.33. The Healthcare Providers & Services industry median PB Ratio is 1.99. NDatalyze's value of 13.33 is 571.5% above this industry median. Based on the distribution chart, NDatalyze ranks #557 out of 608 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does NDatalyze's PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, NDatalyze ranks #557 out of 608 companies for PB Ratio. This places NDatalyze in the lower half of its industry. The industry median PB Ratio is 1.99. NDatalyze's value of 13.33 is 571.5% above this benchmark. Historically, NDatalyze's own PB Ratio has ranged from 0.94 to 13.33 over the past decade. While the company's 10-year median is 4.44 vs. the industry median of 1.99, NDatalyze has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.99, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NDatalyze's current PB Ratio of 13.33 is 571.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on NDatalyze and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NDatalyze's current PB Ratio is 13.33, which is 200% above median its own 10-year median of 4.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NDatalyze stock overvalued right now?
Based on GuruFocus' analysis, NDatalyze (NDATF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.05, compared to a current price of $0.08 — trading 60% above its estimated fair value. The current PB Ratio is 13.33, which is 200% above median its 10-year median of 4.44 and 571.5% above the Healthcare Providers & Services industry median of 1.99. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For NDatalyze (NDATF), the current PB Ratio is 13.33 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NDatalyze Corp develops technologically-based, specialized products, databases, and applications. The YMI division is developing a data-driven consumer mHealth application designed to predict current and future health conditions to lessen the cost of health services and decrease the load on health care services. The MLdelic division is providing a database platform that may be used to predict potential benefits associated with the use of entheogenic compounds within the mental health sector. The Medxtractor division manufactures small-scale bio-extractors that are used to extract essential oils from botanical materials.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NDATF has been successfully added to your 